CN Patent

CN105085529A — 依鲁替尼新晶型及其制备方法

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2015-11-25 · 10y expired

What this patent protects

本发明涉及依鲁替尼新晶型及其制备方法，属于制药技术领域。所述新晶型的差示扫描量热曲线在194℃-204℃处具有吸热峰，并且具备较好的理化性质，有利于生产中操作，可用于制备药物制剂。

USPTO Abstract

本发明涉及依鲁替尼新晶型及其制备方法，属于制药技术领域。所述新晶型的差示扫描量热曲线在194℃-204℃处具有吸热峰，并且具备较好的理化性质，有利于生产中操作，可用于制备药物制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN105085529A
Jurisdiction
CN
Classification
—
Expires
2015-11-25
Drug substance claim
No
Drug product claim
No
Assignee
Sunshine Lake Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.